1. Home
  2. PHVS vs SMR Comparison

PHVS vs SMR Comparison

Compare PHVS & SMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • SMR
  • Stock Information
  • Founded
  • PHVS 2015
  • SMR 2007
  • Country
  • PHVS Netherlands
  • SMR United States
  • Employees
  • PHVS N/A
  • SMR N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • SMR Electrical Products
  • Sector
  • PHVS Health Care
  • SMR Industrials
  • Exchange
  • PHVS Nasdaq
  • SMR Nasdaq
  • Market Cap
  • PHVS 1.0B
  • SMR 960.6M
  • IPO Year
  • PHVS 2021
  • SMR N/A
  • Fundamental
  • Price
  • PHVS $23.98
  • SMR $18.41
  • Analyst Decision
  • PHVS Buy
  • SMR Buy
  • Analyst Count
  • PHVS 6
  • SMR 5
  • Target Price
  • PHVS $35.67
  • SMR $11.50
  • AVG Volume (30 Days)
  • PHVS 97.2K
  • SMR 14.2M
  • Earning Date
  • PHVS 11-08-2024
  • SMR 11-07-2024
  • Dividend Yield
  • PHVS N/A
  • SMR N/A
  • EPS Growth
  • PHVS N/A
  • SMR N/A
  • EPS
  • PHVS N/A
  • SMR N/A
  • Revenue
  • PHVS N/A
  • SMR $13,856,000.00
  • Revenue This Year
  • PHVS N/A
  • SMR N/A
  • Revenue Next Year
  • PHVS N/A
  • SMR $181.20
  • P/E Ratio
  • PHVS N/A
  • SMR N/A
  • Revenue Growth
  • PHVS N/A
  • SMR N/A
  • 52 Week Low
  • PHVS $15.00
  • SMR $1.81
  • 52 Week High
  • PHVS $33.00
  • SMR $22.75
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 67.84
  • SMR 55.84
  • Support Level
  • PHVS $23.89
  • SMR $16.71
  • Resistance Level
  • PHVS $25.40
  • SMR $22.75
  • Average True Range (ATR)
  • PHVS 1.21
  • SMR 2.29
  • MACD
  • PHVS 0.26
  • SMR -0.15
  • Stochastic Oscillator
  • PHVS 73.79
  • SMR 42.52

About PHVS Pharvaris N.V.

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .

About SMR NuScale Power Corporation

NuScale Power Corp is engaged in the development of a new modular light water reactor nuclear power plant to supply energy for electrical generation, district heating, desalination, hydrogen production, and other process heat applications.

Share on Social Networks: